Glycosaminoglycans (GAGs), such as heparin, heparan sulfate (HS), and chondroitin sulfate (CS), are naturally occurring polydisperse linear polysaccharides that are heavily O- and N-sulfated. The interaction between GAGs and proteins are critical for many biological processes including cell-cell and cell-matrix interactions, cell migration and proliferation, growth factor sequestration, chemokine and cytokine activation, microbial recognition and tissue morphogenesis during embryonic development. Hundreds of HS-binding proteins have been identified, but the oligosaccharide structures that mediate particular interactions have been defined in only a few cases due to the structural complexity of HS. Studies in Technology Research and Development project 3 (TR&D3) are focused on biochemical and genetic approaches to assess proteoglycan (PG) functions through the use of cell-based systems for recombinant target protein and PG expression, biochemical characterization, and cell-based assays for biological function. The technologies are based on platforms for large-scale recombinant PG binding protein expression in mammalian cells for enrichment of GAG ligand structures in TR&D1, structural studies in TR&D2, and for cell-based assays in TR&D3. Interactions with PGs in vivo can be more complex, since natural GAGs are much larger than simple oligosaccharides; they may interact simultaneously with both ligands and their receptors via distinct binding sites, and may also harbor multiple copies of these binding sites. Recombinant production of secreted PGs containing engineered GAG chains for use in biochemical and structural studies and cell-based assays are proposed to extend and validate biochemical findings in a cellular context. Mouse lung endothelial cell (MLEC) lines are being developed harboring gene disruptions in selected steps in heparin sulfate (HS) biosynthesis or modification for structure-activity relationship (SAR) studies to examine cell-based functions of PG core proteins harboring altered GAG chains.
Specific Aims are proposed to:
Aim 1. Express and characterize PG binding proteins as DBP targets for biochemical studies on GAG-protein interactions by epitope enrichment, NMR structural analysis, and high-resolution hydroxyl radical footprinting. PG core proteins harboring engineered GAG chains are also being developed for biochemical, structural, and cell-based studies on biological function.
In Aim 2, development of mutant MLEC lines, cell-based arrays, and PG arrays are proposed for biological SAR studies including development of additional mutant MLEC lines deficient in GAG extension and sulfation, development of HS/CS mutant MLEC-based cell arrays for biological SAR studies, development of PG arrays harboring altered HS structures for SAR studies, and development of competitive cell arrays using structurally defined HS or CS with wild type MLEC cells to examine SARs of HS and CS in ligand interactions and cellular responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Biotechnology Resource Grants (P41)
Project #
5P41GM103390-29
Application #
9414615
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Georgia
Department
Type
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Xu, Xianzhong; Eletsky, Alexander; Sheikh, M Osman et al. (2018) Glycosylation Promotes the Random Coil to Helix Transition in a Region of a Protist Skp1 Associated with F-Box Binding. Biochemistry 57:511-515
Zhao, Yuejie; Yang, Jeong Yeh; Thieker, David F et al. (2018) A Traveling Wave Ion Mobility Spectrometry (TWIMS) Study of the Robo1-Heparan Sulfate Interaction. J Am Soc Mass Spectrom 29:1153-1165
Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Sheikh, Mohammed Osman et al. (2018) CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology. J Biol Chem :
Epp, Alexandra; Hobusch, Juliane; Bartsch, Yannic C et al. (2018) Sialylation of IgG antibodies inhibits IgG-mediated allergic reactions. J Allergy Clin Immunol 141:399-402.e8
Flanagan-Steet, Heather; Christian, Courtney; Lu, Po-Nien et al. (2018) TGF-ß Regulates Cathepsin Activation during Normal and Pathogenic Development. Cell Rep 22:2964-2977
Talsma, Ditmer T; Katta, Kirankumar; Ettema, Marieke A B et al. (2018) Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathy. Lab Invest 98:427-438
Zhang, Peng; Lu, Hong; Peixoto, Rui T et al. (2018) Heparan Sulfate Organizes Neuronal Synapses through Neurexin Partnerships. Cell 174:1450-1464.e23
Schmalstig, Alan A; Benoit, Stéphane L; Misra, Sandeep K et al. (2018) A Non-catalytic Antioxidant Role for Helicobacter pylori Urease. J Bacteriol :
Thieker, David F; Xu, Yongmei; Chapla, Digantkumar et al. (2018) Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase. Sci Rep 8:11832
Amos, Robert A; Pattathil, Sivakumar; Yang, Jeong-Yeh et al. (2018) A two-phase model for the non-processive biosynthesis of homogalacturonan polysaccharides by the GAUT1:GAUT7 complex. J Biol Chem 293:19047-19063

Showing the most recent 10 out of 246 publications